Ordin nr. 1301/500/2008 din 11 iulie 2008 Partea a ii-a
Yüklə 4,39 Mb.
|
- Bu səhifədəki naviqasiya:
- SUBLISTA C1 - G31C ARTROPATIA PSORIAZICA.
| Protocol: L043M
______________________________________________________________________________ | 584 |L01XC02| RITUXIMABUM**** | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L01XC02 RITUXIMABUM CONC. PT. SOL. PERF. 10 mg/ml MABTHERA 100 mg 10 mg/ml ROCHE REGISTRATION LTD. MABTHERA 500 mg 10 mg/ml ROCHE REGISTRATION LTD. ________________________________________________________________________________
| 585 |L04AA11| ETANERCEPTUM**** | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L04AA11 ETANERCEPTUM PULB. + SOLV. PT. 25 mg SOL. INJ. ENBREL 25 mg 25 mg WYETH EUROPA LIMITED L04AA11 ETANERCEPTUM PULB + SOLV. PT. 50 mg SOL. INJ. ENBREL 50 mg 50 mg WYETH EUROPA LIMITED
SOL. INJ. ENBREL 25 mg 25 mg WYETH EUROPA LIMITED
SOL. INJ. ENBREL 50 mg 50 mg WYETH EUROPA LIMITED
PREUMPLUTĂ ENBREL 25 mg 25 mg WYETH EUROPA LIMITED
PREUMPLUTĂ ENBREL 50 mg 50 mg WYETH EUROPA LIMITED ________________________________________________________________________________ ______________________________________________________________________________ | 586 |L04AA12| INFLIXIMABUM**** | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L04AA12 INFLIXIMABUM PULB. PT. CONC. 100 mg PT. SOL. PERF. REMICADE 100 mg 100 mg CENTOCOR B.V. ________________________________________________________________________________
| 587 |L04AA17| ADALIMUMABUM**** | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L04AA17 ADALIMUMABUM SOL. INJ. ÎN SERINGĂ 40 mg PREUMPLUTĂ HUMIRA 40 mg 40 mg ABBOTT LABORATORIES LTD. SUBLISTA C1 - G31C ARTROPATIA PSORIAZICA. Yüklə 4,39 Mb. Dostları ilə paylaş:
|